CICC
ABBV icon

Capital Investment Counsel (Colorado)’s AbbVie ABBV Stock Holding History

Capital Investment Counsel (Colorado)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4M Buy
49,388
+624
+1% +$134K 1.54% 20
2026
Q1 		$10.6M Buy
48,764
+754
+2% +$167K 1.45% 22
2025
Q4 		$11M Buy
48,010
+171
+0.4% +$39K 1.52% 19
2025
Q3 		$11.1M Sell
47,839
-2,482
-5% -$505K 1.63% 16
2025
Q2 		$9.34M Sell
50,321
-1,209
-2% -$225K 1.45% 20
2025
Q1 		$10.8M Sell
51,530
-1,170
-2% -$227K 1.79% 12
2024
Q4 		$9.36M Buy
52,700
+229
+0.4% +$42.1K 1.56% 18
2024
Q3 		$10.4M Buy
52,471
+869
+2% +$162K 1.79% 14
2024
Q2 		$8.85M Buy
51,602
+2,346
+5% +$389K 1.74% 15
2024
Q1 		$8.97M Buy
49,256
+17,555
+55% +$3.03M 1.92% 11
2023
Q4 		$4.91M Buy
+31,701
New +$4.62M 1.85% 13

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Capital Investment Counsel (Colorado)'s ABBV Position: Q2 2026 in Review

Capital Investment Counsel (Colorado) increased its AbbVie (ABBV) stake by 1.3% in Q2 2026, buying an estimated $134K and bringing the position to 49,388 shares worth $12.4M. The position accounts for 1.54% of the portfolio, ranked #20.

Capital Investment Counsel (Colorado) first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 3,018 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Capital Investment Counsel (Colorado) held 49,388 shares of AbbVie worth $12.4M as of Q2 2026.
  • Capital Investment Counsel (Colorado) bought 624 AbbVie shares in Q2 2026, an estimated $134K.
  • AbbVie made up 1.54% of Capital Investment Counsel (Colorado)'s portfolio in Q2 2026, its #20 holding.
  • Capital Investment Counsel (Colorado) first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 3,018 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Capital Investment Counsel (Colorado)'s 13F filing for Q2 2026, filed 15 Jul 2026.